1. Market Overview of NK Cell Therapy
1.1 NK Cell Therapy Market Overview
1.1.1 NK Cell Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 NK Cell Therapy Market Size by Regions: 2015 VS 2021 VS 2026
1.3 NK Cell Therapy Historic Market Size by Regions (2015-2020)
1.4 NK Cell Therapy Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact NK Cell Therapy Sales Market by Type (2015-2026)
2.1 Global NK Cell Therapy Historic Market Size by Type (2015-2020)
2.2 Global NK Cell Therapy Forecasted Market Size by Type (2021-2026)
2.3 NK Cell Therapies
2.4 NK Cell Directed Antibodies
3. Covid-19 Impact NK Cell Therapy Sales Market by Application (2015-2026)
3.1 Global NK Cell Therapy Historic Market Size by Application (2015-2020)
3.2 Global NK Cell Therapy Forecasted Market Size by Application (2021-2026)
3.3 NK Cell Therapy Breakdown Data by Application
3.4 Cancer
3.5 Gastrointestinal Diseases
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global NK Cell Therapy Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global NK Cell Therapy Revenue Market Share by Manufacturers (2015-2020)
4.3 Global NK Cell Therapy Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in NK Cell Therapy Business
5.1 Nektar Therapeutics
5.1.1 Nektar Therapeutics Company Profile
5.1.2 Nektar Therapeutics NK Cell Therapy Product Specification
5.1.3 Nektar Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Innate Pharma SA
5.2.1 Innate Pharma SA Company Profile
5.2.2 Innate Pharma SA NK Cell Therapy Product Specification
5.2.3 Innate Pharma SA NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Affimed
5.3.1 Affimed Company Profile
5.3.2 Affimed NK Cell Therapy Product Specification
5.3.3 Affimed NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Chipscreen Biosciences
5.4.1 Chipscreen Biosciences Company Profile
5.4.2 Chipscreen Biosciences NK Cell Therapy Product Specification
5.4.3 Chipscreen Biosciences NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Fate Therapeutics
5.5.1 Fate Therapeutics Company Profile
5.5.2 Fate Therapeutics NK Cell Therapy Product Specification
5.5.3 Fate Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Glycostem Therapeutics
5.6.1 Glycostem Therapeutics Company Profile
5.6.2 Glycostem Therapeutics NK Cell Therapy Product Specification
5.6.3 Glycostem Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Dragonfly Therapeutics
5.7.1 Dragonfly Therapeutics Company Profile
5.7.2 Dragonfly Therapeutics NK Cell Therapy Product Specification
5.7.3 Dragonfly Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Kiadis Pharma
5.8.1 Kiadis Pharma Company Profile
5.8.2 Kiadis Pharma NK Cell Therapy Product Specification
5.8.3 Kiadis Pharma NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 NantWorks
5.9.1 NantWorks Company Profile
5.9.2 NantWorks NK Cell Therapy Product Specification
5.9.3 NantWorks NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Nkarta Therapeutics
5.10.1 Nkarta Therapeutics Company Profile
5.10.2 Nkarta Therapeutics NK Cell Therapy Product Specification
5.10.3 Nkarta Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Fortress Biotech
5.11.1 Fortress Biotech Company Profile
5.11.2 Fortress Biotech NK Cell Therapy Product Specification
5.11.3 Fortress Biotech NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America NK Cell Therapy Market Size (2015-2026)
6.2 North America NK Cell Therapy Key Players in North America (2015-2020)
6.3 North America NK Cell Therapy Market Size by Type (2015-2020)
6.4 North America NK Cell Therapy Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia NK Cell Therapy Market Size (2015-2026)
7.2 East Asia NK Cell Therapy Key Players in North America (2015-2020)
7.3 East Asia NK Cell Therapy Market Size by Type (2015-2020)
7.4 East Asia NK Cell Therapy Market Size by Application (2015-2020)
8. Europe
8.1 Europe NK Cell Therapy Market Size (2015-2026)
8.2 Europe NK Cell Therapy Key Players in North America (2015-2020)
8.3 Europe NK Cell Therapy Market Size by Type (2015-2020)
8.4 Europe NK Cell Therapy Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia NK Cell Therapy Market Size (2015-2026)
9.2 South Asia NK Cell Therapy Key Players in North America (2015-2020)
9.3 South Asia NK Cell Therapy Market Size by Type (2015-2020)
9.4 South Asia NK Cell Therapy Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia NK Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia NK Cell Therapy Key Players in North America (2015-2020)
10.3 Southeast Asia NK Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia NK Cell Therapy Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East NK Cell Therapy Market Size (2015-2026)
11.2 Middle East NK Cell Therapy Key Players in North America (2015-2020)
11.3 Middle East NK Cell Therapy Market Size by Type (2015-2020)
11.4 Middle East NK Cell Therapy Market Size by Application (2015-2020)
12. Africa
12.1 Africa NK Cell Therapy Market Size (2015-2026)
12.2 Africa NK Cell Therapy Key Players in North America (2015-2020)
12.3 Africa NK Cell Therapy Market Size by Type (2015-2020)
12.4 Africa NK Cell Therapy Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania NK Cell Therapy Market Size (2015-2026)
13.2 Oceania NK Cell Therapy Key Players in North America (2015-2020)
13.3 Oceania NK Cell Therapy Market Size by Type (2015-2020)
13.4 Oceania NK Cell Therapy Market Size by Application (2015-2020)
14. South America
14.1 South America NK Cell Therapy Market Size (2015-2026)
14.2 South America NK Cell Therapy Key Players in North America (2015-2020)
14.3 South America NK Cell Therapy Market Size by Type (2015-2020)
14.4 South America NK Cell Therapy Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World NK Cell Therapy Market Size (2015-2026)
15.2 Rest of the World NK Cell Therapy Key Players in North America (2015-2020)
15.3 Rest of the World NK Cell Therapy Market Size by Type (2015-2020)
15.4 Rest of the World NK Cell Therapy Market Size by Application (2015-2020)
16 NK Cell Therapy Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.